[HTML][HTML] The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

YL Zhang, JQ Yuan, KF Wang, XH Fu, XR Han… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Objectives Estimate the epidermal growth factor receptor (EGFR) mutation prevalence in all
non-small cell lung cancer (NSCLC) patients and patient subgroups. Results A total of 456 …

[PDF][PDF] The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

pdfs.semanticscholar.org
The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review
and meta-analysis Page 1 Oncotarget 78985 www.impactjournals.com/oncotarget …

[引用][C] The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

YL Zhang, JQ Yuan, KF Wang, XH Fu, XR Han… - Oncotarget, 2016 - cir.nii.ac.jp
The prevalence of <i>EGFR</i> mutation in patients with non-small cell lung cancer: a
systematic review and meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報 …

[HTML][HTML] The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

YL Zhang, JQ Yuan, KF Wang, XH Fu, XR Han… - Oncotarget, 2016 - oncotarget.com
The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review
and meta-analysis | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial …

[PDF][PDF] The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

core.ac.uk
The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review
and meta-analysis Page 1 Oncotarget 78985 www.impactjournals.com/oncotarget …

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

YL Zhang, JQ Yuan, KF Wang, XH Fu, XR Han… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Objectives Estimate the epidermal growth factor receptor (EGFR) mutation prevalence in all
non-small cell lung cancer (NSCLC) patients and patient subgroups. Results A total of 456 …

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.

YL Zhang, JQ Yuan, KF Wang, XH Fu, XR Han… - Oncotarget, 2016 - europepmc.org
Objectives Estimate the epidermal growth factor receptor (EGFR) mutation prevalence in all
non-small cell lung cancer (NSCLC) patients and patient subgroups. Results A total of 456 …

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

YL Zhang, JQ Yuan, KF Wang, XH Fu, XR Han… - …, 2016 - eprints.whiterose.ac.uk
Objectives: Estimate the epidermal growth factor receptor (EGFR) mutation prevalence in all
non-small cell lung cancer (NSCLC) patients and patient subgroups. Results: A total of 456 …

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

YL Zhang, JQ Yuan, KF Wang, XH Fu, XR Han… - Oncotarget, 2016 - oncotarget.com
The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review
and meta-analysis | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial …